Xenotransplantation could either be a friend or foe of healthcare equity
- PMID: 38734795
- PMCID: PMC11088630
- DOI: 10.1038/s43856-024-00511-0
Xenotransplantation could either be a friend or foe of healthcare equity
Abstract
There are critical shortages in donor organs available for transplantation in the United States, with some racial and ethnic groups facing disparities in access. Xenotransplantation is currently an experimental approach, but has the promise of significantly increasing organ supply. Here, we discuss inequities in access to transplantation and the potential role of xenotransplantation in alleviating these inequities.
Conflict of interest statement
The authors declare the following competing interests: Marie Chisholm-Burns serves (unpaid) on the board of directors for the American Society of Transplantation (AST). This manuscript does not represent AST or the board’s opinions or views, but rather the views of the individual authors. Drs. Kelly and Spivey declare no competing interests.
References
-
- Organ Procurement & Transplantation Network. National Data.https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/ (2024).
-
- Organ Procurement & Transplantation Network. How Organ Allocation Works.https://optn.transplant.hrsa.gov/patients/about-transplantation/how-orga... (2024).
-
- National Academies of Science, Engineering, and Medicine. Realizing the promise of equity in the organ transplantation system. In A consensus study report. Proc. Natl Acad. Sci. USA 1-254 (National Academies Press, Washington, DC, 2022). - PubMed
LinkOut - more resources
Full Text Sources